Add Formweb to your mobile device
Approved Formulary
REMS FDA Documents (opioids)
Search results for:
oxyCODONE
oxyCODONE
Brand names: OxyCONTIN, RoxiCODONE, Xtampza ER
| Form | Strength |
|---|---|
| SOLUTION, ORAL | 5 mg/5 mL |
| TABLET, EXTENDED RELEASE, ORAL | 10 mg; 15 mg; 20 mg; |
| TABLET, ORAL | 5 mg; 30 mg |
Display Opioid Agonists Class:
280808
Medication comments:
| Per policy, orders for these non-formulary agents will be changed to formulary equivalents. | |
|---|---|
| Non-Formulary Agent | Formulary Equivalent |
| oxyCODONE ER (Xtampza) 9 mg capsule q12h | oxyCODONE ER (OxyCONTIN) 10 mg tablet q12h |
| oxyCODONE ER (Xtampza) 13.5 mg capsule q12h | oxyCODONE ER (OxyCONTIN) 15 mg tablet q12h |
| oxyCODONE ER (Xtampza) 18 mg capsule q12h | oxyCODONE ER (OxyCONTIN) 20 mg tablet q12h |
| oxyCODONE ER (Xtampza) 27 mg capsule q12h | oxyCODONE ER (OxyCONTIN) 30 mg tablet q12h |
| oxyCODONE ER (Xtampza) 36 mg capsule q12h | oxyCODONE ER (OxyCONTIN) 40 mg tablet q12h |
Last updated: Jun. 11, 2025
- Black Box Warnings Oral solution: Risk of errors
- Black Box Warnings Controlled release: Abuse potential
- Look-Alike/Sound-Alike oxyCODONE confused with HYDROcodone, oxybutynin, OxyCONTIN, oxyMORphone
Class II